Martin Shkreli on Pharma Co./Stock Valuation: Discussing Ligand, Thinks Mgmt 'Runs a Really Good Co.,' But Highlights There is Always a Chance for a Discrepancy with Co. and Stock Valuation
Paul Quintaro